Pulmonary research in 2013 and beyond: a National Heart, Lung, and Blood Institute perspective.
作者信息
Kiley James P, Senior Robert M
出版信息
Am J Physiol Lung Cell Mol Physiol. 2012 Nov 1;303(9):L729-32. doi: 10.1152/ajplung.00305.2012. Epub 2012 Sep 7.
Abstract
摘要
相似文献
1
Pulmonary research in 2013 and beyond: a National Heart, Lung, and Blood Institute perspective.2013年及以后的肺部研究：美国国立心肺血液研究所的观点。
Am J Physiol Lung Cell Mol Physiol. 2012 Nov 1;303(9):L729-32. doi: 10.1152/ajplung.00305.2012. Epub 2012 Sep 7.
2
On the value of portfolio diversity in heart, lung, and blood research.论心脏、肺和血液研究中投资组合多样性的价值。
Circ Res. 2012 Sep 14;111(7):833-6. doi: 10.1161/CIRCRESAHA.112.279596. Epub 2012 Aug 13.
3
National Heart, Lung, and Blood Institute resources and programs for gene therapy in heart, lung, and blood diseases.美国国立心肺血液研究所关于心脏、肺部和血液疾病基因治疗的资源与项目。
Circ Res. 2007 Jun 22;100(12):1667-9. doi: 10.1161/CIRCRESAHA.107.101201.
4
The Max Planck Institute for Heart and Lung Research Curiosity-Driven Basic Research to Fight Cardio-Pulmonary Diseases.
Circ Res. 2017 Apr 28;120(9):1386-1389. doi: 10.1161/CIRCRESAHA.117.310763.
5
The ambitions and goals of the National Heart, Lung, and Blood Institute at The National Institute of Health.美国国立卫生研究院下属的国家心肺血液研究所的抱负与目标。
Eur Heart J. 2009 May;30(10):1155-6. doi: 10.1093/eurheartj/ehp150.
6
Precision medicine for lung diseases: A National Heart, Lung, and Blood Institute perspective.肺部疾病的精准医学：美国国立心肺血液研究所的观点
Ann Allergy Asthma Immunol. 2019 Dec;123(6):537-538. doi: 10.1016/j.anai.2019.07.001. Epub 2019 Jul 4.
7
Nanotechnology research support at the National Heart, Lung, and Blood Institute.美国国立心肺血液研究所的纳米技术研究支持。
Circ Res. 2011 Jul 22;109(3):250-4. doi: 10.1161/RES.0b013e31822a97cd.
8
Notes from the director of the National Heart, Lung, and Blood Institute: shaping the future of research: the NHLBI strategic plan.美国国立心肺血液研究所所长笔记：塑造研究的未来：美国国立心肺血液研究所战略计划
Circulation. 2007 Nov 20;116(21):2479-80. doi: 10.1161/CIRCULATIONAHA.107.740951.
9
National heart, lung, and blood institute (NHLBI) strategic visioning: setting an agenda together for the NHLBI of 2025.美国国立心肺血液研究所（NHLBI）战略构想：共同为2025年的NHLBI制定议程。
Circulation. 2015 Mar 24;131(12):1106-9. doi: 10.1161/CIRCULATIONAHA.115.015712. Epub 2015 Feb 23.
10
Cell therapy for lung diseases. Report from an NIH-NHLBI workshop, November 13-14, 2012.细胞疗法治疗肺部疾病。NIH-NHLBI 研讨会报告，2012 年 11 月 13 日至 14 日。
Am J Respir Crit Care Med. 2013 Aug 1;188(3):370-5. doi: 10.1164/rccm.201303-0522WS.
引用本文的文献
1
Stem cells, cell therapies, and bioengineering in lung biology and diseases. Comprehensive review of the recent literature 2010-2012.干细胞、细胞疗法和生物工程在肺生物学和疾病中的应用。对 2010-2012 年近期文献的综合回顾。
Ann Am Thorac Soc. 2013 Oct;10(5):S45-97. doi: 10.1513/AnnalsATS.201304-090AW.
2
Lung stem and progenitor cells.肺干/祖细胞。
Respiration. 2013;85(2):89-95. doi: 10.1159/000346500. Epub 2013 Feb 11.
本文引用的文献
1
OBSTRUCTIVE LUNG DISEASE AND EXPOSURE TO BURNING BIOMASS FUEL IN THE INDOOR ENVIRONMENT.阻塞性肺病与室内环境中生物质燃料燃烧暴露
Glob Heart. 2012 Sep 1;7(3):265-270. doi: 10.1016/j.gheart.2012.06.016. Epub 2012 Sep 25.
2
Activation of AMP-activated protein kinase α2 by nicotine instigates formation of abdominal aortic aneurysms in mice in vivo.烟碱激活 AMP 激活的蛋白激酶 α2 促使体内形成小鼠的腹主动脉瘤。
Nat Med. 2012 Jun;18(6):902-10. doi: 10.1038/nm.2711.
3
Next-generation regeneration: the hope and hype of lung stem cell research.下一代再生：肺干细胞研究的希望与炒作。
Am J Respir Crit Care Med. 2012 Jun 15;185(12):1255-60. doi: 10.1164/rccm.201202-0228PP. Epub 2012 Apr 19.
4
Mitochondrial transfer from bone-marrow-derived stromal cells to pulmonary alveoli protects against acute lung injury.骨髓基质细胞向肺泡转移线粒体可防止急性肺损伤。
Nat Med. 2012 Apr 15;18(5):759-65. doi: 10.1038/nm.2736.
5
Improving the cardiovascular health of the US population.改善美国民众的心血管健康。
JAMA. 2012 Mar 28;307(12):1314-6. doi: 10.1001/jama.2012.361. Epub 2012 Mar 16.
6
Trends in cardiovascular health metrics and associations with all-cause and CVD mortality among US adults.美国成年人心血管健康指标的变化趋势及其与全因和 CVD 死亡率的关系。
JAMA. 2012 Mar 28;307(12):1273-83. doi: 10.1001/jama.2012.339. Epub 2012 Mar 16.
7
Inflammatory biomarkers improve clinical prediction of mortality in chronic obstructive pulmonary disease.炎症生物标志物可改善慢性阻塞性肺疾病患者死亡的临床预测。
Am J Respir Crit Care Med. 2012 May 15;185(10):1065-72. doi: 10.1164/rccm.201110-1792OC. Epub 2012 Mar 15.
8
Subclinical interstitial lung disease: why you should care.亚临床间质性肺疾病：您为何需要关注。
Am J Respir Crit Care Med. 2012 Jun 1;185(11):1147-53. doi: 10.1164/rccm.201108-1420PP. Epub 2012 Feb 23.
9
Fetal and infant growth and asthma symptoms in preschool children: the Generation R Study.胎儿和婴儿期生长与学龄前儿童哮喘症状：荷兰鹿特丹“生育队列研究”。
Am J Respir Crit Care Med. 2012 Apr 1;185(7):731-7. doi: 10.1164/rccm.201107-1266OC. Epub 2012 Jan 20.
10
Shifting of immune responsiveness to house dust mite by influenza A infection: genomic insights.流感 A 感染导致对屋尘螨免疫应答的转变：基因组学的见解。
J Immunol. 2012 Jan 15;188(2):832-43. doi: 10.4049/jimmunol.1102349. Epub 2011 Dec 14.
Zotero 插件